Vericel (VCEL) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 48.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.72% |
| Dec 31, 2025 | 34.32% |
| Sep 30, 2025 | 87.04% |
| Jun 30, 2025 | 60.13% |
| Mar 31, 2025 | 16.77% |
| Dec 31, 2024 | 7.86% |
| Sep 30, 2024 | -11.23% |
| Jun 30, 2024 | 16.89% |
| Mar 31, 2024 | 1.79% |
| Dec 31, 2023 | 35.29% |
| Sep 30, 2023 | -7.27% |
| Jun 30, 2023 | -23.25% |
| Mar 31, 2023 | 11.09% |
| Dec 31, 2022 | -25.26% |
| Sep 30, 2022 | 19.55% |
| Jun 30, 2022 | 8.29% |
| Mar 31, 2022 | -4.29% |
| Dec 31, 2021 | 103.24% |
| Sep 30, 2021 | 25.39% |
| Jun 30, 2021 | -7.08% |
| Mar 31, 2021 | 27.47% |
| Dec 31, 2020 | 25.03% |
| Sep 30, 2020 | 17.91% |
| Jun 30, 2020 | 297.89% |
| Mar 31, 2020 | 30.04% |
| Dec 31, 2019 | 47.05% |
| Sep 30, 2019 | -30.75% |
| Jun 30, 2019 | -85.26% |
| Dec 31, 2018 | -31.93% |
| Dec 31, 2014 | 276.51% |
| Sep 30, 2014 | 247.43% |
| Jun 30, 2014 | 62.44% |
| Dec 31, 2013 | -40.91% |
| Sep 30, 2013 | -48.71% |
| Jun 30, 2013 | -84.32% |
| Mar 31, 2013 | -74.88% |
| Dec 31, 2012 | 146.62% |
| Sep 30, 2012 | 76.52% |
| Jun 30, 2012 | 54.78% |
| Mar 31, 2012 | 49.19% |
| Dec 31, 2011 | -82.30% |
| Sep 30, 2011 | -17.41% |
| Jun 30, 2011 | 31.18% |